ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-925 Cr | ₹-745 Cr | ₹-639 Cr | ₹-637 Cr | ₹-582 Cr |
What is the latest Cash Flow from Financing Activities ratio of ABBOTT INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-925 Cr |
| Mar2024 | ₹-745 Cr |
| Mar2023 | ₹-639 Cr |
| Mar2022 | ₹-637 Cr |
| Mar2021 | ₹-582 Cr |
How is Cash Flow from Financing Activities of ABBOTT INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-925 Cr | Negative | |
| Mar2024 | ₹-745 Cr | Negative | |
| Mar2023 | ₹-639 Cr | Negative | |
| Mar2022 | ₹-637 Cr | Negative | |
| Mar2021 | ₹-582 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹60,391.0 Cr | 1.6% | -2.5% | -2.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,782.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,376.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,225.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,174.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,629.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 1.6% |
-2.5% |
-2.7% |
| SENSEX | -0.3% |
-0.5% |
8.3% |
You may also like the below Video Courses